Potency of fragmented IgG: two studies of postexposure prophylaxis in type A hepatitis
- PMID: 122995
Potency of fragmented IgG: two studies of postexposure prophylaxis in type A hepatitis
Abstract
To determine the effect of fragmentation on potency of immune globulin preparations, two comparisons were carried out. In one study, the immune globulin was derived from American plasma; in the other, the source was Israeli plasma. In each of the two studies, three materials were given to household contacts of icteric hepatitis: (1) human albumin as a placebo; (2) immune globulin with the IgG intact; and (3) immune globulin of the same lot with the IgG deliberately fragmented by added fibrinolysin. Comparable reductions in secondary attack rates were achieved with fragmented and unfragmented materials from both lots. Fragmentation, therefore, had no deleterious effect. In addition, it was found that American globulin is comparable to Israeli globulin for protection against strains of Type A hepatitis prevalent in Israel. Administration in the second half (last 15 days) of the incubation period did not reduce the frequency of icteric disease.
Similar articles
-
Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases.Pediatrics. 1996 Dec;98(6 Pt 1):1207-15. Pediatrics. 1996. PMID: 8951284 Review.
-
Cost-benefit of mass prophylaxis with immune serum globulin to control waterborne hepatitis A: a case study.Isr J Med Sci. 1986 Mar-Apr;22(3-4):277-82. Isr J Med Sci. 1986. PMID: 3091532
-
A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study.Gastroenterology. 1977 Jan;72(1):111-21. Gastroenterology. 1977. PMID: 318578 Review.
-
Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.Pediatr Infect Dis J. 2007 Jan;26(1):36-40. doi: 10.1097/01.inf.0000247105.45185.13. Pediatr Infect Dis J. 2007. PMID: 17195703
-
Pre-exposure prophylaxis with immune serum globulin for prevention of viral hepatitis in army recruits.J Epidemiol Community Health. 1982 Sep;36(3):176-82. doi: 10.1136/jech.36.3.176. J Epidemiol Community Health. 1982. PMID: 6754845 Free PMC article. Clinical Trial.
Cited by
-
Similarities of two hepatitis A virus strains.Bull World Health Organ. 1976;54(5):561-4. Bull World Health Organ. 1976. PMID: 194718 Free PMC article.
-
Assessment of immunoglobulin use for hepatitis A control in New Mexico.Public Health Rep. 1982 Nov-Dec;97(6):516-20. Public Health Rep. 1982. PMID: 7146301 Free PMC article.